Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

http://www.businessweek.com/stories/2002-05-26/table-the-race-for-a-cancer-treatment

Magazine

Table: The Race for a Cancer Treatment


COMPANY: AstraZeneca

DRUG: Iressa (pill)

TARGET: Growth signals inside the cancer cell

DISEASE: Lung cancer. Also being tested against breast, colon, gastric, and prostate cancer

STATUS: FDA application filed in Dec. 2001; decision expected in June

COMPANY: ImClone Systems

DRUG: Erbitux (intravenous injection)

TARGET: Growth-signal receptor on surface of cancer cell

DISEASE: Colon cancer. Also being tested against head and neck, pancreatic, and breast cancer

STATUS: FDA application rejected in Dec. 2001; expected to refile by yearend


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus